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and Jonathan I. Bisson a*
aDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK; bPsychology and
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ABSTRACT
Background: Internet-delivered Cognitive Behavioural Therapy (i-CBT) offers potential as an
alternative, accessible, clinically and cost-effective treatment for post-traumatic stress dis-
order (PTSD), but little is known about its acceptability.
Objective: To review the available evidence to understand the acceptability of i-CBT for
PTSD.
Method: We undertook a mixed-methods systematic review according to Cochrane
Collaboration Guidelines, of randomised controlled trials (RCTs) of i-CBT for adults with
PTSD. We examined included studies for measures of acceptability, and possible proxy
indicators of acceptability, including dropout rates, which were meta-analysed as risk ratios
(RRs).
Results: Ten studies with 720 participants were included. We found i-CBT to be acceptable
according to specific acceptability measures, and suggestions for acceptability according to
some proxy measures of i-CBT programme usage. There was, however, evidence of greater
dropout from i-CBT than waitlist (RR 1.39, CI 1.03–1.88; 8 studies; participants = 585) and no
evidence of a difference in dropout between i-CBT and i-non-CBT (RR 2.14, CI 0.97–4.73;
participants = 132; 2 studies).
Conclusion: i-CBT appears a potentially acceptable intervention for adults with PTSD. We
identified clinical and research questions, including the status of proxy indicators, and call
for standardised, consistent treatment acceptability measurement.
Aceptabilidad de la terapia cognitivo conductual basada en internet
(i-TCC) para Trastorno de Estrés Postraumático (TEPT): una revision
sistemática
Antecedentes: La terapia cognitivo conductual entregada a través de internet (i-TCC) ofrece
potencial como un tratamiento alternativo accesible, clínicamente eficaz y costo-efectivo
para el trastorno de Estrés Postraumático (TEPT), pero se conoce poco acerca de su
aceptabilidad.
Objetivo: Revisar la evidencia disponible para comprender la aceptabilidad de i-TCC para TEPT.
Método: Realizamos una revisión sistemática de métodos mixtos de acuerdo a las Guías de
la Colaboración Cochrane, de estudios aleatorizados controlados (RCT por sus sigla en
inglés) de i-TCC para adultos con TEPT. Examinamos los estudios incluídos buscando
medidas de aceptabilidad, y posibles indicadores indirectos de aceptabilidad, incluyendo
tasas de abandono, los que fueron meta-analizados como Riesgo Relativo (RR).
Resultados: Diez estudios con 720 participantes fueron incluídos. Encontramos que i-TCC
era aceptable de acuerdo a medidas específicas de aceptabilidad y sugerencias de su
aceptabilidad de acuerdo a algunas medidas indirectas del uso del programa de i-TCC.
Hubo, sin embargo, evidencia de un mayor abandono desde i-TCC que Lista de Espera (RR
1.39, IC 1.03-1.88; 8 estudios, participantes = 585) y no hubo diferencia en abandono entre
i-TCC y otras intervenciones a través de internet no TCC (RR 2.14, IC 0.97-4.73; participantes
= 132; 2 estudios).
Conclusión: i-TCC aparece como una intervención potencialmente aceptable para adultos
con TEPT. Identificamos preguntas clínicas y de investigación, incluyendo el estado de los
indicadores indirectos, y la necesidad de medidas de aceptabilidad estandarizadas
y consistentes.
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• Standardised, consistent
acceptability measurement
is needed.
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基于网络的认知行为疗法（i-CBT）对创伤后应激障碍（PTSD）的可接受
性：一项系统综述
背景：网上认知行为疗法（i-CBT）为创伤后应激障碍（PTSD）提供了一种更易获得和成
本效果比更高的临床性替代治疗方法，但我们对其可接受性知之甚少。
目的：综述现有的证据，以了解i-CBT治疗PTSD的可接受性。
方法：我们根据Cochrane协作指南，对患有PTSD的成人的i-CBT随机对照试验（RCT）进
行了混合方法系统综述。我们考查了所纳入的研究的可接受性指标（包括脱落率），并
将这些指标元分析化为风险比（RRs）。
结果：根据纳入的10项包括720名参与者的研究，我们发现i-CBT在特定可接受性指标上表
现尚可，并根据i-CBT使用的一些代理指标提出增加可接受性的建议。然而，有证据表明i-
CBT的辍学率高于等候名单组（RR 1.39，CI 1.03-1.88； 8项研究；被试 = 585），并没有
证据表明i-CBT和i-non-CBT之间的脱落率有差异（ RR 2.14，CI 0.97-4.73；参与者= 132； 2
项研究）。
结论：对于患有PTSD的成人i-CBT似乎是可接受的干预方法。我们还确认了临床和研究的
相关问题，包括代理指标的状态。标准化的、一致的测量可接受性的指标亟待确立。
1. Introduction
Trauma-Focused Cognitive Behavioural Therapy
(TF-CBT) is widely evidenced as an effective treat-
ment of choice for PTSD (Bisson, Roberts, Andrew,
Cooper, & Lewis, 2013), recommended in interna-
tional clinical guidelines (Forbes, Creamer, Bisson,
Cohen, Crow, Foa, . . . Ursano, 2010). TF-CBT
includes therapies for PTSD sufferers that facilitate
an individual to challenge his/her thoughts, beliefs
and/or behaviour, and typically include psychoeduca-
tion, cognitive and exposure work, stress/relaxation
management, and homework. Timely delivery of TF-
CBT is important, not least in minimising further
potential impact of PTSD, including the development
of other mental/physical health problems, impaired
functioning, and maladaptive coping mechanisms
(Rauch et al., 2009; Roberts, Roberts, Jones, &
Bisson, 2016).
Timely PTSD treatment, including TF-CBT, is not
always feasible, with long treatment waiting lists result-
ing from a limited number of therapists qualified in its
delivery (Lovell & Richards, 2000). Another barrier in
accessing traditional PTSD treatments, such as TF-CBT
is the commitment required for weekly face-to-face
appointments over several months, something which
may not be suitable for all patients (Maercker &
Knaevelsrud, 2007). Furthermore, TF-CBT, for exam-
ple, is not covered by national health services or health
insurances in all countries (Kazlauskas et al., 2016),
thereby excluding individuals, in such countries, who
cannot afford such treatment.
Internet-delivered CBT (i-CBT), an alternative to
therapist-delivered CBT, offers potential as an effec-
tive mode of delivery of CBT, promising increased
treatment accessibility and cost-effectiveness (Gratzer
& Khalid-Khan, 2016). I-CBT includes internet-based
programmes to treat PTSD sufferers, using CBT or
TF-CBT approaches, and may be self-guided or
therapist-guided. I-CBT interventions for PTSD gen-
erally offer less therapist contact than in traditional
face-to-face TF-CBT, and guidance varies across
i-CBT interventions, for example a higher level of
therapist involvement, feedback and encouragement,
week-to-week, is required in the PTSD i-CBT inter-
vention, Interapy (Lange, Rietdijk, Hudcovicova, van
de Ven, J.-P.,Schrieken, B., & Emmelkamp, 2003),
compared with the intervention, PTSD Online
(Klein et al., 2010), which does not require weekly
feedback from therapists. Effective across a range of
mental health problems, including anxiety disorders
and depression (Lewis, Pearce, & Bisson, 2012),
i-CBT interventions have also been tested for PTSD,
and found to be superior to waitlist and treatment-as-
usual, in reducing symptoms of depression and
PTSD, with greater effect when guided by
a therapist (Lewis, Roberts, Bethell, Robertson, &
Bisson, 2018). In recognition of the developing evi-
dence base, guided i-CBT with a trauma-focus has
featured amongst treatment recommendations in
recent treatment guidelines for PTSD (ISTSS, 2018).
Treatment acceptability may influence adherence
(Santana & Fontenelle, 2011) and outcome (Swift &
Callahan, 2009), and a growing demand for patient
choice in healthcare treatment, including PTSD treat-
ment (Tarrier, Liversidge, & Gregg, 2006), suggests
an increasing need for accurate information about
treatment acceptability in addition to treatment effi-
cacy. A facet of healthcare quality, acceptability is
reported increasingly across the literature, however,
explicit theories and definitions are lacking, and mea-
surements vary widely. In a review of 43 studies
across health care interventions, no explicit theory
or definition for acceptability was found (Sekhon,
Cartwright, & Francis, 2017), with over half (k =
23), of the studies assessing acceptability by objective
measures of uptake/adherence, with dropout rates the
most commonly relied on measure, which is reflected
in the acceptability literature.
Most systematic reviews of psychological treat-
ment for PTSD have focused on efficacy, with some
reporting acceptability alongside, commonly with
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respect to dropout. For example, a Cochrane review
(Bisson et al., 2013), considered dropout rates as
a primary outcome, finding most of the 70 included
studies reported dropout rates, with high rates across
many studies. However, acknowledged by the authors
themselves, interpreting acceptability based on drop-
out rate alone may be a limitation, with few studies
providing explanations for dropouts. Furthermore,
outcomes are inconsistently measured for individuals
who dropout, and whilst this might in cases indicate
treatment unacceptability, and non-improvement of
symptoms, research has also shown significant
improvement in symptomatology for individuals dis-
continuing from psychological treatment (Szafranski,
Smith, Gros, & Resick, 2017). Few studies exist that
have directly assessed acceptability of internet-based
treatments for psychological disorders, as a whole, in
terms of treatment preferences, expectations, usabil-
ity, and satisfaction (Campos et al., 2018). It is impor-
tant to understand more about acceptability of i-CBT
interventions for PTSD given that it is a relatively
new treatment in this population, and given that
acceptability is a factor likely to affect implementa-
tion (Wallin, Mattsson, & Olsson, 2016). Therefore,
in addition to understanding acceptability according
to dropout, we also need to consider acceptability
with respect to other factors that might be important,
including usability, or tolerability, particularly impor-
tant given it is an intervention with variable degrees
of therapist contact, sometimes largely, sometimes
solely, self-directed. To illustrate, it may be argued
where there is a considerable reduction, or perhaps
no engagement with a therapist, tolerability may be
problematic, particularly when concerning exposure
work in i-CBT with a trauma-focus, which may
require an individual to recount distressing trauma
memories (Pietrzak, Goldstein, Southwick, & Grant,
2011). Whilst research has shown alliance can be
maintained throughout trauma-focused work
(Capaldi, Asnaani, Zandberg, Carpenter, & Foa,
2016), clinicians frequently report concern about
trauma interventions with exposure, for fear of dis-
rupting therapeutic alliance.
1.1. Aim of the study
Acknowledging acceptability as multi-faceted, we
decided to adopt Sekhon et al.’s definition of accept-
ability (Sekhon et al., 2017, p. 4): ‘a multi-faceted
construct that reflects the extent to which people deli-
vering or receiving a healthcare intervention consider
it to be appropriate, based on anticipated or experi-
enced cognitive and emotional responses to the inter-
vention’. Referring to this definition we aimed to
determine if i-CBT is an acceptable psychological
treatment for adults with PTSD, through reviewing
and synthesising current knowledge.
2. Materials and methods
We undertook a mixed-method systematic review of
randomised controlled trials (RCTs) of i-CBT for
adults with PTSD. A protocol was published by
PROSPERO, an international prospective register, in
November 2017 (Simon, Bisson, Lewis, & Barawi,
2017). With no ‘gold standard’ operationalised
acceptability measure, we examined studies using
any standardised measure of acceptability, self-
reported, or clinician-administered, and commonly
reported proxy indicators of acceptability, including
treatment non-uptake and dropout, adverse effects,
and standardised measures of satisfaction.
2.1. Selection criteria
Included studies were RCTs; randomised cross-over
trials; and cluster-randomised trials of i-CBT for
PTSD, for optimal confidence interpreting findings,
given the rigorous methodology/reporting expected
of these designs. For consistency with other reviews
of psychological therapies for PTSD (Lewis et al.,
2018), studies were eligible if at least 70% of partici-
pants were diagnosed with PTSD according to DSM/
ICD criteria, and if participants were aged 16 years or
older. There was no restriction on the index trauma;
severity or duration of symptoms; or length of time
since trauma. Included studies allowed co-morbidity
if PTSD was the primary diagnosis and a reduction in
PTSD symptoms was the primary aim of the inter-
vention. Studies of i-CBT were eligible, including
therapies delivered online and through mobile appli-
cations, with or without therapist guidance, and if
they provided up to a maximum of 5 h of therapist
guidance, delivered face-to-face or remotely. There
were no restrictions on number of interactions with
a therapist or length of the online programme.
Eligible comparator interventions were face-to-face
psychological therapy; waitlist/minimal attention/
repeated assessment/usual care; and non-CBT inter-
net-delivered psychological therapy. Sample size and
publication status were not used to determine inclu-
sion. Studies not published in English were excluded.
2.2. Search strategy
The search strategy used for a review of the efficacy of
i-CBT for PTSD (Lewis et al., 2018), was adopted for
the current review. Search terms were identified and
a systematic search of the Cochrane Common Mental
Disorders Group (CCMDG) clinical trials registers
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databases was performed for studies published up to
2 March 2018 (see Appendix A for full search strategy
terms). These databases are updated weekly from
searches of OVID MEDLINE (from 1950), Embase
(from 1974), and PsycINFO (from 1967), quarterly
searches of the Cochrane Central Register of
Controlled Trials (CENTRAL), and review-specific
searches of additional databases. Reference lists of
studies and systematic reviews identified in the search
were checked and we searched the World Health
Organization’s International Clinical Trials Registry
Platform, to identify additional unpublished/ongoing
studies. We contacted authors of included studies to
identify unpublished/submitted studies and con-
ducted a search of the Published International
Literature on Traumatic Stress (PILOTS) database.
Abstracts of studies identified in the search and full-
text publications of potentially eligible studies were
screened independently by two authors and whilst we
put in place a procedure to resolve any disagreements
with the input of a third reviewer, full inter-rater
agreement meant that this was not required.
2.3. Data extraction
A pre-designed data extraction form enabled systematic
extraction of information on study methodology, parti-
cipant characteristics, interventions, outcomes, and
data on treatment uptake and dropout. Primary mea-
sures of interest were: 1) standardised measure(s) of
acceptability, self-reported or clinician-administered,
at any time point; 2) non-uptake rate, defined as per-
centage of individuals offered but not taking treatment;
3) dropout or lost to follow-up rate from baseline and
prior to treatment completion, as a percentage; 4)
adverse effects, indicated by increased PTSD symptoms
from baseline to last available follow-up, measured
using a standardised scale, for example the Clinician
Administered Scale for PTSD (CAPS-5) (Weathers
et al., 2018), or any other adverse effect reported from
baseline including increased self-harm and suicide; 5)
any standardised measure of satisfaction administered
from baseline; and 6) i-CBT programme usage, for
example module completion/logons/self-reported
usage/homework completion. Measures of acceptabil-
ity, including proxy indicators, were the main outcomes
of interest, rather than the primary outcomes of the
included studies themselves, which was a reduction in
PTSD symptoms in every case.
2.4. Data synthesis
Sufficient quantitative data were available across all
studies for meta-analyses to be conducted for drop-
out, as a proxy of acceptability. Data were entered
into the Cochrane Collaboration’s Review Manager 5
(RevMan-5) software (Review Manager (RevMan),
2014). Categorical outcomes were analysed as risk
ratios (RRs), using 95% confidence intervals.
Clinical heterogeneity was assessed by looking at
variability in the experimental and control interven-
tions, participants, settings, and outcomes. To further
assess heterogeneity, the I2 statistic and the chi-
squared test of heterogeneity, as well as visual inspec-
tion of the forest plots were used. We intended to
pool using a fixed-effect meta-analysis where homo-
geneity was present, and with random-effects meta-
analysis where heterogeneity was present, and we
planned to generate funnel plots to assess reporting
bias if a meta-analysis included more than 10 studies
(Higgins & Green, 2011).
Given the likely limited number of included stu-
dies with insufficiently similar acceptability measures,
we also adopted a narrative synthesis methodology to
bring together evidence, an approach described as
a form of ‘trustworthy story-telling’, and ‘taking
a textual approach to the process of synthesis’
(Popay et al., 2006, p. 5). This allowed us to organise
and describe extracted data which was interpreted
and refined by three of the authors, written up in
a story-telling narrative.
We assessed included studies for risk of bias using
Cochrane criteria (Higgins et al., 2011). This examines
sequence allocation for randomisation; allocation con-
cealment; blinding of assessors; incomplete outcome
data; selective outcome reporting; and any other nota-
ble threats to validity (for example, premature termi-
nation of the study, non-manualised intervention).
Two researchers independently assessed each study
and any discrepancies were discussed with a third
researcher with the aim of reaching a unanimous deci-
sion. Data extraction and synthesis were conducted in
line with Cochrane Collaboration Guidelines (Higgins
et al., 2011), and Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
(Moher, Liberati, Tetzlaff, & Altman, 2009).
3. Results
Figure 1 presents the study selection flow. At the initial
search, 983 studies were identified as potentially eligible.
Abstracts were considered, and we obtained full text
copies for 66 studies deemed as potentially relevant, and
Appendix B lists references to excluded studies. Ten
RCTs of 720 participants met the Review’s inclusion
criteria.
3.1. Characteristics of included studies
Supplementary Table 1 presents a summary of included
studies. Studies compared i-CBT with a waitlist control
group, treatment as usual (TAU) or minimal attention
control group (k = 8), and with an i-non-CBT psycho-
logical intervention (k = 2). Studies were conducted in
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five countries: Australia (k = 1) (Spence et al., 2011);
Iraq (k = 1) (Knaevelsrud, Brand, Lange, Ruwaard, &
Wagner, 2015); Sweden (k = 1) (Ivarsson et al., 2014);
UK (k = 1) (Lewis et al., 2017); and USA (k = 6) (Engel
et al., 2015; Krupnick et al., 2017; Kuhn et al., 2017;
Littleton, Grills, Kline, Schoemann, & Dodd, 2016, Litz
et al., 2007; Miner et al., 2016). Three studies recruited
in clinical settings via clinician referrals (Engel et al.,
2015; Krupnick et al., 2017; Lewis et al., 2017), these
studies also recruited via media, website and promo-
tional material advertising, which was the method used
by the remaining seven studies. The sample size ranged
from 34 to 159 with a mean of 70.1 (SD = 40.29).
Trauma type varied, with three studies concerning ser-
vicemembers withmilitary and terrorist-related trauma
(Engel et al., 2015; Krupnick et al., 2017; Litz et al.,
2007), and one study concerning civilians with war-
related trauma (Knaevelsrud et al., 2015), reporting
moderate to severe PTSD symptoms, overall. Six studies
reported individuals with fairly consistent PTSD seve-
rities of mild to moderate level, one study concerning
rape trauma (Littleton et al., 2016), the others including
a range of traumatic events taking place in the commu-
nity (Ivarsson et al., 2014; Kuhn et al., 2017; Lewis et al.,
2017; Miner et al., 2016; Spence et al., 2011).
The majority of studies excluded individuals
receiving treatment elsewhere, with current psycho-
sis, substance dependence, active suicidal ideation,
and individuals who had recently changed type/
dosage of their mental health medication. Three
studies excluded individuals with comorbid depres-
sion where depression presented immediately prior to
the traumatic event (Litz et al., 2007), and where
symptoms of severe depression presented at assess-
ment (Lewis et al., 2017; Spence et al., 2011), and
another excluded individuals with gross cognitive
impairment (Krupnick et al., 2017). Two studies did
not exclude based on comorbidity, nor suicidal idea-
tion (Kuhn et al., 2017; Miner et al., 2016).
Participants across all studies were aged over 16, the
mean ranging from 22 to 46 years, with a mean
across studies of 42.05 (SD = 8.72), weighted mean
31.77. Nine studies included female and male parti-
cipants, the remaining study reporting 100% female
participants (Littleton et al., 2016). The percentage of
female participants across studies was 66.33% (SD =
32.58), weighted mean of 23.46%.
All participants of included studies met diagnostic
criteria for PTSD, according to DSM-5 (k = 4) (Engel
et al., 2015; Lewis et al., 2017; Litz et al., 2007; Miner
et al., 2016), and DSM-IV (k = 6) (Ivarsson et al.,
2014; Knaevelsrud et al., 2015; Krupnick et al., 2017;
Kuhn et al., 2017; Littleton et al., 2016; Spence et al.,
2011). Outcome measures were clinician-
administered scales in half of the studies, with self-
report measures used in the remaining studies.
Included studies examined the following i-CBT
programmes: Delivery of Self Training and
Education for Stressful Situations (DESTRESS) (k =
2); INTERAPY (k = 1); PTSD Coach (k = 2); From
Survivor to Thriver (k = 1); Spring (Lewis, Roberts,
Vick, & Bisson, 2013) (k = 1); Warriors Internet
Recovery & Education (WIRED) (k = 1); a non-
specified internet-based CBT (k = 2). PTSD Coach
was the only stand-alone programme, with no gui-
dance, examined by two included studies, and the
extent/nature of guidance for the guided programmes
examined by the remaining studies was widely vari-
able. Only one study reported face-to-face guidance,
comprising an hour-long introductory session and
fortnightly 30-min appointments thereafter, face-to-
face or by phone, according to patient preference,
with a trauma therapist, amounting to a mean thera-
pist input per participant of 147.53 min (SD = 57.01)
(Lewis et al., 2017). The remainder of studies
reported limited email/telephone check-in contact,
for example one study reported ‘brief check-ins’ by
Clinical Psychology students, approximately once
fortnightly (Littleton et al., 2016). Of the eight studies
of guided i-CBT, six reported guiding clinician qua-
lifications, and three reported their training on the
i-CBT programme. Three studies used non-trauma-
focused i-CBT programmes: DESTRESS (primary
care version) and PTSD Coach. The i-CBT pro-
grammes were trauma-focused in the other studies,
Figure 1. Flow diagram for study selection.
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and the common components were: psychoeduca-
tion; distress management techniques; cognitive
restructuring/trauma processing; and relapse preven-
tion. Duration of treatment ranged from 4 weeks
(Miner et al., 2016) to 14 weeks (Littleton et al.,
2016), averaging 8.3 weeks (SD = 2.65), across
studies.
3.2. Methodological quality of studies
Figure 2 presents the risk of bias assessments.
Method of sequence allocation was judged to pose
‘low’ risk of bias for seven studies, the remainder
rated ‘unclear’ due to insufficient details. Allocation
concealment was judged ‘low’ risk for three studies,
the remainder rated ‘unclear’. The outcome asses-
sor was aware of the participant’s allocation in two
of the studies, with the remaining studies using
blinded-raters or self-report questionnaires deliv-
ered in a way that could not be influenced by
members of the research team. Incomplete outcome
data were judged to be ‘high’ risk for four studies,
and the remainder were felt to have dealt with
dropouts appropriately. Selective reporting was
judged ‘low’ risk across studies. We could not rule
out potential researcher allegiance, since treatment
originators evaluated i-CBT in all but one of the
studies. Sample sizes were often small, however, all
studies presented objectives.
3.3. Measures of acceptability
Not one of the studies used a standardised/validated
acceptability measure; however, three used measures
developed specifically for their studies (Krupnick
et al., 2017; Miner et al., 2016; Spence et al., 2011).
Questions addressed whether individuals had learned
new tools/skills/techniques to manage symptoms,
whether they would recommend the programme to
a friend with PTSD, and opinions/experience using
the programme. Qualitative data were collected from
participants randomised to the experimental treat-
ment arms in three studies, that compared to waitlist,
and responses were noted as ‘extremely enthusiastic’
in one of these studies (Krupnick et al., 2017), with
moderate to high acceptability responses also
reported in the other studies (Miner et al., 2016;
Spence et al., 2011). For example in one study, nearly
83% of participants in the i-CBT arm reported they
had learned new tools to cope with their symptoms
(Miner et al., 2016). Similarly, acceptability was found
in another study, assessed in the experimental treat-
ment group using the Distress/Endorsement
Validation Scale (DEVS) (Devilly, 2004), with 76%
of individuals reporting they would recommend the
treatment to others (Knaevelsrud et al., 2015).
3.4. Treatment satisfaction
Post-treatment satisfaction was measured in the
experimental treatment arms in two studies, and
found to be high (Littleton et al., 2016; Spence
et al., 2011): one used the Satisfaction with Therapy
and Therapist Scale-Revised (STTS-R), measuring
satisfaction with one’s therapist and with treatment
received (Oei & Green, 2008); the other used
a measure of satisfaction, based on a standardised
Credibility/Expectancy questionnaire, measuring
satisfaction with the programme, and quality of cor-
respondence with therapist, and treatment modules.
3.5. Therapeutic alliance
Eight studies examined i-CBT programmes guided by
a therapist, the other two being stand-alone pro-
grammes (Kuhn et al., 2017; Miner et al., 2016). We
did not set out to look at therapeutic alliance, given
research on therapeutic alliance in i-CBT is growing
but limited (Maercker & Knaevelsrud, 2007); how-
ever, it is widely considered an essential ingredient in
psychotherapy (Bordin, 1979), and was measured
post-treatment in the experimental treatment arm in
one guided i-CBT study (Littleton et al., 2016), using
the Working Alliance Inventory-Short form (WAI-S)
(Horvath & Greenberg, 1989). Strong alliance was
reported across three areas of measurement: agree-
ment of therapeutic tasks; bond between therapist
and client; and mutual endorsement of therapeutic
goals.
3.6. Non-uptake and dropout
Five studies reported non-uptake, defined as the
number of individuals offered but not taking up
treatment (Engel et al., 2015; Lewis et al., 2017;
Littleton et al., 2016; Litz et al., 2007; Spence et al.,
2011). Non-uptake for two studies comparing i-CBT
with active treatment comparators reported 18.60%
for i-CBT, and 0% for optimised care (Engel et al.,
2015), and 15.22% for i-CBT, and 14.63% for psycho-
education website comparison (Littleton et al., 2016).
Non-uptake in the remaining studies that reported
this information did not differentiate between experi-
mental arms, and overall there was insufficient data
to conduct meaningful non-uptake meta-analyses.
Dropout ranged from 8.69% to 62.5% and was
higher in the i-CBT intervention across all but two
of the studies, both studies of guided, trauma-focused
i-CBT interventions compared to waitlist
(Knaevelsrud et al., 2015; Spence et al., 2011). There
was statistically significant evidence for greater drop-
out from i-CBT compared with waitlist/TAU/mini-
mal attention (k = 8; n = 585; RR 1.39; CI 1.03–1.88),
as shown in Figure 3. There was no evidence of
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greater dropout from i-CBT than i-non-CBT (k = 2;
n = 132; RR 2.14; CI 0.97–4.73), as shown in Figure 4.
Interestingly, dropout was higher for i-CBT, com-
pared with waitlist/usual care/minimal attention for
two of the three included studies that concerned non-
trauma-focused i-CBT programmes (Kuhn et al.,
2017; Miner et al., 2016), as can be seen in Figure 3.
Two studies attempted to record dropout reasons
with rates. Knaevelsrud et al. (2015) reported few
responses with some individuals noting technical
problems, lack of privacy to use the programme
undisturbed. Lewis et al. (2017 reported eight parti-
cipants dropped out (19.05%), with two individuals
reporting a lack of time to dedicate to the pro-
gramme, two finding the programme difficult, one
feeling symptoms had improved, and three indivi-
duals did not provide a reason.
3.7. I-CBT programme usage
Programme usage was reported by most studies, in
a range of formats, including information on module/
homework completion, logons, and self-reported
usage. Three studies reported the percentage of indi-
viduals completing all programme modules, from
35% to 38.71% (Engel et al., 2015; Ivarsson et al.,
2014; Lewis et al., 2017). Two studies examining
PTSD Coach found mean, self-reported weekly
usages of 2.65 times per week (SD = 1.03) and 2.27
days per week (SD = 1.76), in the treatment groups
(Kuhn et al., 2017; Miner et al., 2016). Engel el at
(Engel et al., 2015) reported 65% of participants com-
pleted at least 6 of the 18 expected logins, with 35%
completing all logins. Spence et al. (2011), reported
the highest level of engagement, with a mean of 6.74
‘lessons’ completed (SD = 0.54), the total number of
lessons being seven, strong homework compliance,
with 81% reporting 20 min or more daily homework
practice, and participants downloaded the majority
(85%) of the additional resources available.
3.8. Adverse effects
Only two studies reported the presence/absence of
adverse effects. One study (Littleton et al., 2016)
noted two individuals in the intervention condition
reported a clinically significant increase in depression
symptoms post-treatment, with one of these indivi-
duals also reporting a clinically significant increase in
anxiety symptoms. It is, however, difficult to attribute
this to i-CBT as, sadly, these individuals had also both
experienced the death of an immediate family mem-
ber during treatment. Three additional individuals
reported clinically significant increases in anxiety at
post-treatment. With respect to the control condition,
one individual experienced a clinically significant
increase in depression symptoms between post-
treatment and follow-up. No studies reported
increased PTSD symptoms from baseline to last avail-
able follow-up.
4. Discussion
Encouragingly, high levels of i-CBT acceptability
were reported for treatment group participants
according to measures of acceptability, satisfaction
and therapeutic alliance, and usage of the i-CBT
programmes was promising, indicating acceptability.
Contrastingly, lower levels of acceptability were
inferred through non-uptake and dropout rates.
Figure 2. Methodological quality of included studies.
Risk of bias judgments for each study (in seven domains: A = random
sequence generation; B = allocation concealment;l; C = blinding of
assessors; D = incomplete data; E = selective reporting; F = other
bias) are illustrated to the right of the forest plots (green/+ = low
risk; yellow/? = unclear risk; red/- = high risk).
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Non-uptake was higher in the i-CBT groups in two
studies reporting this information in both the i-CBT
and active treatment comparison groups, 18.60%
(Engel et al., 2015), and 15.22% (Littleton et al.,
2016), suggesting a considerable proportion of indi-
viduals not engaging with i-CBT interventions for
PTSD. Combined dropout across all 10 studies was
greater for i-CBT, though comparable to dropout
reported for face-to-face therapy (Klein et al., 2009).
The findings are not atypical of some of the uptake
and dropout literature for PTSD. A review of barriers
to uptake of computerised-CBT (Waller & Gilbody,
2009), reports high acceptability among individuals
participating in studies, yet low uptake rates, with
explanations suggested, including perceived stigma
around research participation. With respect to drop-
out, high dropout rates were reported in the range of
14–62% in a systematic review of eMental health
interventions for PTSD, with 40 included studies
(Gaebel et al., 2017). Comparable dropout rates
have been shown for i-CBT, face-to-face and other
internet-interventions for PTSD (Klein et al., 2009),
though overall, PTSD clinical trial dropout rates are
notably variable in the literature, with several possible
explanations, including potential research participa-
tion burden, completing lengthy questionnaires
(Sanders et al., 2012), and level of perseverance in
contacting hard to reach participants. Tolerability for
PTSD treatment is another potential explanation,
perhaps impacted by varying levels of therapeutic
alliance (Imel, Laska, Jakupcak, & Simpson, 2013).
Higher dropout has been demonstrated for TF-CBT
compared with CBT non-trauma-focused, and com-
pared to waitlist/usual care (Bisson et al., 2013, 2007).
It is possible that elements of the trauma-focused
i-CBT interventions in the included studies may
have increased distress levels, albeit possibly tempora-
rily, resulting in some dropout. Indeed, a study of the
guided i-CBT PTSD Online (Klein et al., 2009), found
high alliance ratings, despite low/moderate levels of
programme satisfaction, the authors suggesting ‘par-
ticipants may have found some of the program con-
tent difficult (e.g. exposure modules); however
communication with their therapist was strong and
may have mediated these effects’ (p.129). However,
tolerability is unlikely to be the sole explanation,
given the finding of higher dropout for i-CBT, com-
pared with waitlist/usual care/minimal attention, for
two of the three included studies concerning non-
trauma-focused i-CBT programmes (Miner, Kuhn),
as can be seen in Figure 3.
4.1. Strengths and limitations
We found several limitations of the research on i-CBT
acceptability. Though we report acceptability of i-CBT
for PTSD, according to specific acceptability measures
and suggestions for acceptability according to i-CBT
programme usage, the lack of standardised measures
of acceptability across the literature in general (Sekhon
et al., 2017), is one limitation. Additionally, only par-
ticipants in the experimental arms of the included
studies were asked questions regarding acceptability,
a limitation likely to affect many studies across the
literature. And a study reporting high levels of satisfac-
tion and working alliance did not obtain this
information from individuals who did not complete
the post-treatment assessment (Littleton et al., 2016).
Acknowledged by the authors themselves, this is
a limitation, and again is one which will likely affect
many studies across the literature. Due to wide
Figure 3. Dropout forest plots for i-CBT vs waitlist/usual care/minimal attention.
i-CBT versus wait list.
Figure 4. Dropout forest plots for i-CBT vs i-non-CBT.
i-CBT versus i-non-CBT.
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variability in measurement/reporting of i-CBT pro-
gramme usage across the literature, also evident across
the included studies, from self-report questions to
direct login information, it was not possible to make
direct comparisons between studies to draw a clear
conclusion. Similarly, the wide variability in the nat-
ure/extent/quality of guidance, and the guiding clini-
cians training in the programmes, so often seen in the
literature, and evident in the present review, also make
it difficult to meaningfully synthesise information and
draw firm conclusions. All programmes were based on
cognitive-behavioural approaches, with common com-
ponents of psychoeducation, distress management
techniques, cognitive restructuring/trauma processing,
and relapse prevention, though there was still some
heterogeneity across i-CBT programmes, so we must
be cautious in our interpretation of the findings.
However, we considered this clinical heterogeneity
alongside the statistical homogeneity of dropout data
and were able to pool data using fixed-effect meta-
analyses (Higgins & Green, 2011).
The contrasting picture of lower levels of accept-
ability according to dropout rates might be
explained by the limited usefulness as dropout an
indicator for acceptability (Szafranski et al., 2017).
Despite being the most commonly reported indica-
tor of acceptability in the present review, and
reflected elsewhere in the literature (Sekhon et al.,
2017), it is difficult to interpret dropout given the
lack of reported reasons. Only four studies in the
present review reported reasons or provided refer-
ence to their attempted collection (Knaevelsrud
et al., 2015; Krupnick et al., 2017; Lewis et al.,
2017; Spence et al., 2011), and the picture was
similar for non-uptake. Arguably an individual
might drop out of treatment due to a perceived
sense of feeling better, or conversely might engage
with a treatment despite perceiving it to be unac-
ceptable. Of course, dropout must indicate treat-
ment unacceptability, and non-improvement of
symptoms, in some cases, however research has
shown improvement in symptomatology for
a considerable proportion (35.85–55.56%) of
individual(s) who discontinued psychotherapy for
PTSD and depression (Szafranski et al., 2017).
For optimal confidence interpreting findings, elig-
ibility was limited to RCTs, given the rigorous meth-
odology/reporting expected of this design, though we
accept the inclusion of other designs may have pro-
vided additional acceptability information. We fol-
lowed rigorous Cochrane Collaboration guidelines
(Higgins et al., 2011), with two authors independently
screening abstracts/relevant papers, against inclusion
criteria, extracting data and rating risk of bias. Risks
of bias were identified, limiting our confidence in the
quality of the studies.
We included comparison groups of face-to-face and
non-CBT internet-delivered psychological therapy;
waitlist/minimal attention/repeated assessment/usual
care, and we acknowledge the potential limitation of
the comparison group heterogeneity. The number of
included studies was small, and given that we included
only published papers, we must acknowledge the pos-
sible influence of publication bias. Also, we excluded
studies not published in English, limiting generalisa-
bility. Whilst there were enough studies to calculate
meta-analysis of dropout (Valentine, Pigott, &
Rothstein, 2010), it may be argued that the meta-
analyses comparisons lack statistical power, given
that power was not calculated a priori (Hedges &
Pigott, 2001), and we did not consider it appropriate
to conduct post-hoc power analysis (Hoenig & Heisey,
2001). There was an insufficient number of studies to
investigate reporting bias.
Several studies relied on PTSD diagnosis based on
self-report measures, and the predominant methods
of recruitment were media/website advertising,
potentially limiting generalisability of the findings
since not all participants were necessarily treatment-
seeking. Nonetheless, our review did not restrict on
sample size, index trauma, time since trauma, sever-
ity/duration of symptoms, and we decided to
include studies with a minimum of 70% of indivi-
duals with a PTSD diagnosis, as well as allowing for
comorbidity, so there is good reason to believe our
findings could be cautiously generalised to clinical
populations.
4.2. Clinical/treatment implications
Guided i-CBT has featured amongst treatment
recommendations in recent treatment guidelines for
PTSD (ISTSS, 2018), and offers promise as another
treatment of choice, addressing the growing demand
for patient choice in healthcare treatment, including
PTSD treatment (Tarrier et al., 2006). Understanding
the clinical utility of i-CBT for individuals with PTSD
is of critical importance, and must give weight to
acceptability, widely recognised as vital in the roll-
out of health care interventions (Craig & Petticrew,
2013). I-CBT for individuals with PTSD offers poten-
tial as a cost-effective, timely and accessible treatment
choice, especially for individuals who might have
difficulty committing to standard treatment of weekly
appointments (Maercker & Knaevelsrud, 2007),
potentially reducing long waiting lists in mental
health services.
Treatment uptake, retention and adherence reflect
the broader domains of behaviour constituting
engagement; therefore, clinicians might consider
adopting strategies that might be influential in enga-
ging individuals with PTSD in an i-CBT intervention.
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These might include motivational/shared decision-
making strategies, and enhancing patient/clinician
communication, for example facilitating trauma
information disclosure, through establishing
a strong therapeutic alliance (Capaldi et al., 2016;
Christensen, Griffiths, & Farrer, 2009; Kehle-Forbes
& Kimerling, 2017; Maercker & Knaevelsrud, 2007).
Clinical practice might also consider the integration
of such interventions within stepped-care models
(Ebert et al., 2018), appreciating its value as a form
of treatment in its own right, whilst also emphasising
the ongoing role of individual therapy for more com-
plex presentations (Waller & Gilbody, 2009).
4.3. Research implications
Further research is required in the growing field of
i-CBT, which recognises acceptability as a priority
outcome in itself, and as an additional factor likely
to affect its implementation as a treatment interven-
tion (Kaltenthaler et al., 2008). We need to further
understand factors associated with i-CBT treatment
acceptability and efficacy, including acceptability’s
potential role as a mediator of treatment outcome,
in order to facilitate the development of optimised
i-CBT for PTSD targeted to individuals who might
benefit most (Klein et al., 2010).
The growing literature points towards advantages
of guided, over unguided i-CBT in PTSD (Lewis
et al., 2012). Indeed, guided interventions were used
in the two included studies in the present review that
showed lower attrition in the i-CBT group, compared
with waitlist (Knaevelsrud et al., 2015; Spence et al.,
2011). However, the study with most guidance (Lewis
et al., 2017) showed greater dropout in the immediate
i-CBT group, and whilst there may be several expla-
nations, therapist input per se does not seem to be the
answer and further research is required to understand
the relationship between guidance in i-CBT interven-
tions and treatment acceptability.
To develop knowledge in the field of treatment
acceptability, and to inform the development of accep-
table i-CBT programmes for PTSD, we put forward
recommendations. Firstly, the development and rou-
tine use of validated, reliable acceptability measures
that include measures of treatment satisfaction, ther-
apeutic alliance, intervention usage and adherence.
Also, standardised methodology for assessment and
reporting of acceptability in mental health and psycho-
logical treatment studies. And for further exploration
of the reliability of proxy measures of acceptability,
particularly dropout. Routine, standardised collection
of non-uptake and dropout, including reasons, would
be an important step in understanding clinical trial
participation generally, as well as in understanding
the picture in terms of PTSD treatment acceptability.
These recommendations would lead to new studies
which may be directly comparable, enabling a clearer
understanding of key factors that determine the
acceptability of i-CBT.
5. Conclusion
Overall, i-CBT appears a potentially acceptable inter-
vention for adults with PTSD. Despite indications of
lower levels of acceptability according to dropout
rates, higher levels of acceptability were indicated
for treatment group participants according to mea-
sures of acceptability, and i-CBT programme usage.
We identified clinical and research questions, includ-
ing the status of proxy indicators, and call for stan-
dardised, consistent treatment acceptability
measurement, to lead to acceptable and effective
i-CBT interventions for PTSD.
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